784 articles
Physicist-turned-longevity scientist argues aging can be modeled with stress, damage, and noise — and most interventions barely scratch the surface.
Decades of aspirin optimism are being upended. New trial data shows low-dose aspirin may increase cancer mortality in older adults.
Three research teams point to pesticides, gut bacteria, and ultra-processed foods as drivers of early-onset colorectal cancer.
A new ADNI-linked study raises red flags about omega-3 and cognitive decline — but supplement quality may be the real culprit.
New research links the shingles vaccine to dramatically reduced cardiac events and lower dementia risk — here's what the evidence shows.
A physician breaks down the expanding benefits of GLP-1 medications — from heart and kidney health to joints and cancer — and why tirzepatide wins.
A grad student's discovery exposed major contamination errors in microplastics studies, casting doubt on alarming health claims.
A single base-editing injection reduced PCSK9 by 88% in trials. Could this permanently solve the #1 killer?
A KRAS-targeting drug earned a standing ovation at ASCO 2026 by doubling survival in one of cancer's deadliest forms.
A new class of drugs targeting myostatin may preserve muscle during weight loss, changing body composition forever.
A $12 sunscreen ingredient long used in Europe and Asia is now FDA-cleared and may be the best anti-aging skin tool available.
Bryan Johnson offers guidance on peptides — what they are, how they work, and what health-optimizers should consider before using them.
